)
Visual21 Nov 2025
Data center suppliers
Acurx Pharmaceuticals (ACXP) investor relations material
Acurx Pharmaceuticals Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary12 Nov, 2025
Executive summary
Regained full compliance with NASDAQ listing requirements after a 1-for-20 reverse stock split and meeting equity thresholds.
Granted a new Australian patent for DNA polymerase IIIC inhibitors, expanding global IP protection for the ACX-375C program.
Increased authorized shares from 200 million to 250 million following stockholder approval.
Presented new data on ibezapolstat’s microbiome-sparing properties at IDWeek and published structural biology research in Nature Communications.
Focused on developing novel antibiotics targeting Gram-positive bacteria, with ibezapolstat advancing toward Phase 3 trials for C. difficile infections.
Financial highlights
Ended Q3 2025 with $5.9 million in cash, up from $3.7 million at year-end 2024.
Raised $1.7 million during the quarter via equity line of credit and $1.4 million post-quarter from warrant exercise.
Q3 2025 net loss was $2 million ($1.23 per diluted share), improved from $2.8 million ($3.45 per share) in Q3 2024.
Net loss for the nine months ended September 30, 2025 was $6.4 million ($5.01 per share), improved from $11.3 million ($14.23 per share) year-over-year.
Research and development expenses for Q3 2025 were $0.4 million, down from $1.2 million year-over-year due to lower manufacturing and consulting costs.
Outlook and guidance
Ibezapolstat is Phase 3 ready, with plans to begin international clinical trials next year, subject to financing.
Current cash is not sufficient to meet anticipated requirements for at least 12 months; additional financing will be needed.
Exploring public-private partnerships and alternative pathways for phase III trial funding.
Operating expenses expected to remain steady or decrease further due to ongoing cost-cutting measures.
Anticipates potential major partnership or development news by the next earnings call.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Acurx Pharmaceuticals earnings date
Q4 202516 Mar, 2026
Next Acurx Pharmaceuticals earnings date
Q4 202516 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Acurx Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing antibiotic treatments for bacterial infections. The company's research and development efforts are primarily centered on addressing antibiotic resistance, targeting bacterial pathogens that pose a significant threat to public health. Acurx utilizes a novel approach to inhibit bacterial DNA synthesis, working to combat infections that are increasingly resistant to traditional antibiotics. Its pipeline includes various antibiotic candidates aimed at providing new therapeutic options for patients. The company is headquartered in Staten Island, New York, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage